MYGN vs MSFT: Which Stock is Better?
Side-by-side comparison of Myriad Genetics Inc and Microsoft Corporation in 2026
MYGN
Myriad Genetics Inc
$3.19
MSFT
Microsoft Corporation
$499.32
Key Metrics Comparison
| Metric | MYGN | MSFT | Winner |
|---|---|---|---|
| Market Cap | $413.68M | $3.71T | MSFT |
| P/E Ratio | N/A | 33.89 | MYGN |
| EPS (TTM) | $N/A | $14.08 | MSFT |
| Revenue Growth | -3.6% | 18.4% | MSFT |
| Gross Margin | 0.0% | 67.9% | MSFT |
Analyze MYGN
Full quant analysis
Analyze MSFT
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is MYGN or MSFT a better investment?
Comparing MYGN and MSFT: Myriad Genetics Inc has a market cap of $413.68M while Microsoft Corporation has $3.71T. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between MYGN and MSFT?
MYGN (Myriad Genetics Inc) and MSFT (Microsoft Corporation) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: MYGN or MSFT?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: MYGN or MSFT?
MSFT has higher revenue growth at 18.4% vs -3.6% for MYGN.
Which company is more profitable: MYGN or MSFT?
Microsoft Corporation (MSFT) has higher gross margins at 67.9% compared to 0.0% for MYGN.
Which is the larger company: MYGN or MSFT?
Microsoft Corporation (MSFT) is larger with a market cap of $3.71T compared to $413.68M for MYGN.
Should I buy MYGN or MSFT in 2026?
Both MYGN and MSFT have investment merit. MYGN trades at $3.19 while MSFT trades at $499.32. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between MYGN and MSFT stock?
Key differences: Market Cap ($413.68M vs $3.71T), P/E Ratio (N/A vs 33.9x), Revenue Growth (-3.6% vs 18.4%), Gross Margin (0.0% vs 67.9%).
Should I buy MYGN or MSFT in 2026?
The choice between MYGN and MSFT depends on your investment goals. MSFT shows higher revenue growth (18.4%). MSFT has better margins (67.9%). Consider your risk tolerance and time horizon.
What is the market cap comparison between MYGN and MSFT?
MYGN (Myriad Genetics Inc) has a market cap of $413.68M, while MSFT (Microsoft Corporation) has a market cap of $3.71T. MSFT is the larger company by market value.